Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Ma Chung: Sains, Teknologi, dan Klinis Komunitas Jurnal Ilmiah Manuntung: Sains Farmasi dan Kesehatan
Rayna Iza Azyra
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Gambaran Peresepan Obat Antikolesterol Pada Pasien Geriatri di RS Bhayangkara Anton Soedjarwo Pontianak Periode Januari-Februari 2023 Rayna Iza Azyra; Rika
Jurnal Farmasi Ma Chung: Sains, Teknologi, dan Klinis Komunitas Vol. 2 No. 2 (2024): Jurnal Farmasi Ma Chung: Sains, Teknologi, dan Klinis Komunitas
Publisher : Program Studi Farmasi, Universitas Ma Chung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33479/jfmc.v2i2.36

Abstract

Hypercholesterolemia is a disease that is the main cause of total death in Indonesia and the world. The prevalence of hypercholesterolemia in the world is around 45%, in Southeast Asia around 30%, in Indonesia 35% and in West Kalimantan 37.7%. In handling it, the prescription picture is crucial to reduce the risk of errors inprescribing anticholesterol drugs. The purpose of this study was to determine how the prescription of anticholesterol drugs in geriatric patients at Bhayangkara Anton Soedjarwo Pontianak Hospital for the period January-February 2023. This study included quantitative descriptive research using medical record data of outpatient geriatric patients who received anticholesterol drugs. Determination of the amount of sample data with the Lemeshow formula obtained as many as 100 samples with simple random sampling technique. The results obtained were the most cholesterol sufferers at the age of 61-65 years as much as 22% with female gender as much as 56%. The most widely used anticholesterol drug is Atorvastatin as much as 78%, with a dose of 20 mg, the frequency of use once a day as much as 98%, and the most comorbidities are heart disease 49%. The results showed that the mostprescribed anti-cholesterolemia drug was Atorvastatin.
EVALUASI PERESEPAN OBAT ANTIKOLESTEROL PADA PASIEN GERIATRI PERIODE JANUARI-FEBRUARI 2023 Heny Puspasari; Deny Kusuma; Rayna Iza Azyra
Jurnal Ilmiah Manuntung: Sains Farmasi Dan Kesehatan Vol. 11 No. 2 (2025): Jurnal Ilmiah Manuntung: Sains Farmasi dan Kesehatan
Publisher : Sekolah Tinggi Ilmu Kesehatan Samarinda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51352/jim.v11i2.923

Abstract

Hypercholesterolemia is a disease that is a leading cause of total mortality in Indonesia as well as worldwide. The prevalence of hypercholesterolemia is approximately 45% globally, around 30% in Southeast Asia, 35% in Indonesia, and 37.7% in West Kalimantan. In the management of hypercholesterolemia, evaluation and prescription patterns are crucial to reduce the risk of errors in prescribing anti-cholesterol drugs. The aim of this study was to evaluate the prescription of anti-cholesterol drugs in geriatric patients at Bhayangkara Anton Soedjarwo Hospital, Pontianak, during the period of January–February 2023. This study is a quantitative descriptive study using prescription data from outpatient geriatric patients receiving anti-hypercholesterolemia medication. The sample size was determined using the Lemeshow formula, resulting in 100 respondents selected through simple random sampling. The results showed that hypercholesterolemia patients were most prevalent in the 61–65-year age group, accounting for 22%, with females comprising 56%. The most frequently used anti-cholesterol drug was Atorvastatin (78%), with a dose of 20 mg, administered once daily in 98% of cases, and the most common comorbidity was heart disease (49%). The use of anti-cholesterol drugs was considered rational if it met the criteria of correct diagnosis, correct patient, correct disease indication, correct drug selection, and correct dosage, achieving a rationality rate of 100%. The study findings indicate that the most frequently prescribed anti-hypercholesterolemia drug was Atorvastatin, with rational prescribing practices observed in hypercholesterolemia patients.
Co-Authors Deny Kusuma Puspasari, Heny Rika